American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome
    Journal Article

    Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Results from phase I extension study assessing pexidartinib treatment in six cohorts with solid tumors including TGCT, and abnormal CSF1 transcripts in TGCT
    Journal Article

    Tap, W. D.; Singh, A. S.; Anthony, S. P.; Sterba, M.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Inactivation of AMPK leads to attenuation of antigen presentation and immune evasion in lung adenocarcinoma
    Journal Article

    Gao, Y.; Päivinen, P.; Tripathi, S.; Domènech-Moreno, E.; Wong, I. P. L.; Vaahtomeri, K.; Nagaraj, A. S.; Talwelkar, S. S.; Foretz, M.; Verschuren, E. W.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Pathology: Hub and integrator of modern, multidisciplinary [precision] oncology
    Editorial

    The AACR Pathology Task Force
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A high-content screen for C/EBPα expression identifies novel therapeutic agents in dedifferentiated liposarcoma
    Journal Article

    Angeles, C. V.; Velez, A.; Rios, J.; Laxa, B.; Shum, D.; Ruiz, P. D.; Shen, Y.; Ostrovnaya, I.; Gularte-Mérida, R.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Adavosertib with chemotherapy in patients with primary platinum-resistant ovarian, fallopian tube, or peritoneal cancer: An open-label, four-arm, phase II study
    Journal Article

    Moore, K. N.; Chambers, S. K.; Hamilton, E. P.; Chen, L. M.; Oza, A. M.; Ghamande, S. A.; Konecny, G. E.; Plaxe, S. C.; Spitz, D. L.; Geenen, J. J. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • High FGFR1–4 mRNA expression levels correlate with response to selective FGFR inhibitors in breast cancer
    Journal Article

    Sánchez-Guixé, M.; Hierro, C.; Jiménez, J.; Viaplana, C.; Villacampa, G.; Monelli, E.; Brasó-Maristany, F.; Ogbah, Z.; Parés, M.; Guzmán, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: